{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:02:51Z","timestamp":1787166171980,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.healun.2006.04.011","type":"journal-article","created":{"date-parts":[[2006,7,19]],"date-time":"2006-07-19T11:01:58Z","timestamp":1153306918000},"page":"1070-1076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Prostaglandin E1 Testing in Heart Failure\u2013associated Pulmonary Hypertension Enables Transplantation: The PROPHET Study"],"prefix":"10.1016","volume":"25","author":[{"given":"Wolfgang","family":"von Scheidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Costard-Jaeckle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Ulrich","family":"Stempfle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario C.","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Schwaab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Haaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Naegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Mohacsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Trautnitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2006.04.011_bib1","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/01.CIR.102.14.1718","article-title":"Secondary pulmonary hypertension in chronic heart failure","volume":"102","author":"Moraes","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2006.04.011_bib2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199207093270202","article-title":"An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension","volume":"327","author":"Christman","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2006.04.011_bib3","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/01.CIR.93.2.266","article-title":"Role of nitric oxide in the local regulation of pulmonary vascular resistance in humans","volume":"93","author":"Cooper","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2006.04.011_bib4","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","article-title":"Expression of endothelin-1 in the lungs of patients with pulmonary hypertension","volume":"328","author":"Giaid","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2006.04.011_bib5","first-page":"1581","article-title":"Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamc variables and endothelin levels","volume":"26","author":"Nootens","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.healun.2006.04.011_bib6","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1161\/01.CIR.89.5.2035","article-title":"Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans","volume":"89","author":"Stamler","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2006.04.011_bib7","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0022-5223(97)70053-9","article-title":"Cardiac and pulmonary replacement","volume":"114","author":"Chen","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2006.04.011_bib8","first-page":"48","article-title":"Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group","volume":"19","author":"Costard-Jaeckle","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.healun.2006.04.011_bib9","first-page":"526","article-title":"Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation","volume":"9","author":"Erickson","year":"1990","journal-title":"J Heart Transplant"},{"key":"10.1016\/j.healun.2006.04.011_bib10","first-page":"549","article-title":"Pretransplantation risk factors for death after heart transplantation: a multiinstitutional study","volume":"12","author":"Bourge","year":"1993","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2006.04.011_bib11","first-page":"519","article-title":"Indikationen, Kontraindikationen und differentialtherapeutische Alternativen der Herztransplantation","volume":"85","year":"1996","journal-title":"Z Kardiol"},{"key":"10.1016\/j.healun.2006.04.011_bib12","first-page":"923","article-title":"The evolving management of acute right-sided heart failure in cardiac transplant recipients","volume":"38","author":"Stobierska-Dzierzek","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.healun.2006.04.011_bib13","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/0002-8703(93)90704-D","article-title":"Preoperative pulmonary hemodynamics and early mortality after ortotopic cardiac transplantation: the Pittsburgh experience","volume":"126","author":"Murali","year":"1993","journal-title":"Am Heart J"},{"key":"10.1016\/j.healun.2006.04.011_bib14","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.healun.2004.07.013","article-title":"Mild vs severe pulmonary hypertension before heart transplantation: different effects on posttransplantation pulmonary hypertension and mortality","volume":"24","author":"Chang","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2006.04.011_bib15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0003-4975(89)90785-6","article-title":"Amrinone versus conventional therapy in pulmonary hypertensive patients awaiting cardiac transplantation","volume":"48","author":"Deeb","year":"1989","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2006.04.011_bib16","first-page":"179","article-title":"Pulmonary vasodilatation after heart transplantation","volume":"12","author":"Kieler-Jensen","year":"1993","journal-title":"J Heart Lung Transplantat"},{"key":"10.1016\/j.healun.2006.04.011_bib17","first-page":"366","article-title":"Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance","volume":"13","author":"Kieler-Jensen","year":"1994","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2006.04.011_bib18","first-page":"436","article-title":"Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside","volume":"14","author":"Kieler-Jensen","year":"1995","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2006.04.011_bib19","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1161\/01.CIR.92.6.1539","article-title":"Short-term pulmonary vasodilatation with l-arginine in pulmonary hypertension","volume":"92","author":"Metha","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2006.04.011_bib20","first-page":"716","article-title":"Utility of prostaglandin E1 in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension","volume":"11","author":"Murali","year":"1992","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2006.04.011_bib21","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1161\/01.CIR.0000034444.31846.F4","article-title":"Endothelin mediates increased pulmonary vascular tone in patients with heart failure","volume":"106","author":"Ooi","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2006.04.011_bib22","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1161\/01.CIR.101.25.2922","article-title":"Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure","volume":"101","author":"Givertz","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2006.04.011_bib23","first-page":"133","article-title":"Pharmacologic testing of the reversibility of an increased pulmonary vascular resistance before heart transplantation with prostaglandin I2 (prostacyclin)","volume":"88","author":"Trautnitz","year":"1999","journal-title":"Z Kardiol"},{"key":"10.1016\/j.healun.2006.04.011_bib24","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.healun.2004.04.016","article-title":"Nitric oxide versus prostaglandin E1 for reduction of pulmonary hypertension in heart transplant candidates","volume":"24","author":"Radovancevic","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2006.04.011_bib25","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0195-668X(02)00700-5","article-title":"The EuroHeart Failure Survey Programme: a survey on quality of care among patients with heart failure in Europe","volume":"24","author":"Komajda","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2006.04.011_bib26","doi-asserted-by":"crossref","first-page":"55A","DOI":"10.1016\/S0002-9149(99)80384-1","article-title":"Role of pharmacologic tests in the treatment of primary pulmonary hypertension","volume":"75","author":"Galie","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2006.04.011_bib27","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1161\/01.CIR.90.6.2780","article-title":"Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction","volume":"90","author":"Loh","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2006.04.011_bib28","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1053-2498(03)00183-9","article-title":"Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: first annual report 2003","volume":"22","author":"Deng","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2006.04.011_bib29","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0140-6736(95)91504-4","article-title":"Evidence for endothelin-1 mediated vasoconstriction in severe chronic heart failure","volume":"346","author":"Kiowski","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.healun.2006.04.011_bib30","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1161\/01.CIR.98.21.2262","article-title":"Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure","volume":"98","author":"Suetsch","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2006.04.011_bib31","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0140-6736(05)77807-7","article-title":"Short-term hemodynamic effects of BQ-123, a selective endothelin ET(A)-receptor antagonist, in chronic heart failure","volume":"352","author":"Cowburn","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.healun.2006.04.011_bib32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0002-8703(97)70105-4","article-title":"A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: the Flolan International Randomized Survival Trial (FIRST)","volume":"134","author":"Califf","year":"1997","journal-title":"Am Heart J"},{"key":"10.1016\/j.healun.2006.04.011_bib33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1054\/jcaf.2002.126486","article-title":"Recent heart failure trials of neurohormonal modulation (Overture and Enable): approaching the asymptote of efficacy?","volume":"8","author":"Teerlink","year":"2002","journal-title":"J Card Fail"},{"key":"10.1016\/j.healun.2006.04.011_bib34","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S1053-2498(98)00064-3","article-title":"Bridging to heart transplantation: prostaglandin E1 versus prostacyclin versus dobutamine","volume":"18","author":"Stanek","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2006.04.011_bib35","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1388-9842(03)00059-X","article-title":"Reversible pulmonary hypertension in heart transplant candidates\u2014pretransplant evaluation and outcome after orthotopic heart transplantation","volume":"5","author":"Klotz","year":"2003","journal-title":"Eur J Heart Fail"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249806003342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249806003342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:14:06Z","timestamp":1760948046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249806003342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S1053249806003342"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2006.04.011","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostaglandin E1 Testing in Heart Failure\u2013associated Pulmonary Hypertension Enables Transplantation: The PROPHET Study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2006.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}